Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Lilly/Amylin’s Byetta Type 2 Diabetes Therapy To Launch June 1

Apr 29 2005

• By Jessica Merrill

Related Content

Byetta Is “Approvable” As Stand-Alone Therapy

Apr 29 2005

Amylin’s Symlin Diabetes Therapy Gets FDA Nod

Mar 16 2005

Lilly/Amylin Submit Exenatide For Type 2 Diabetes; Could Be Insulin Alternative

Jun 30 2004

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window